NBI-NearFocus Assisted Cold Snare Polypectomy Improves the Complete Resection Rate of Small Colorectal Polyps: a Prospective Single-arm Observational Study
1 other identifier
interventional
236
1 country
1
Brief Summary
NBI-NearFocus can assist cold snare polypectomy (CSP) to remove small colorectal polyps, but its specific efficacy is not clear.The aim of this study was to assess the efficacy of CSP with NBI-NearFocus evaluation of polypectomy sites for removal of small colorectal polyps. And then formulate a standard operating procedure for cold snare removal of polyps.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedFirst Submitted
Initial submission to the registry
September 4, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 19, 2024
September 1, 2024
11 months
September 4, 2024
September 14, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Histopathological complete resection rate
2-3 days
Secondary Outcomes (1)
Complete recovery rate of polyps
2-3 days
Study Arms (1)
NBI-NearFocus
OTHERNarrow Band Imaging-NearFocus
Interventions
Eligibility Criteria
You may qualify if:
- ① Outpatient or inpatient patients aged 18-85 years old;
- ② Untamed, subpodial, and flat polyps with a diameter of 5-9mm (Paris classification: O-Is O-Isp、O-IIa;JNET Classification: Typel, Type2A);
- ③ Patients who agree to participate in this study.
You may not qualify if:
- Individuals currently taking antiplatelet or anticoagulant drugs, or those with coagulation dysfunction (PT prolongation greater than 3 seconds);
- Polyp diameter\<5mm or ≥ 10mm, morphology does not conform or JNET classification ≥ Type 2B;
- Individuals with severe heart, lung, liver and kidney dysfunction or severe mental disorders who cannot cooperate with the examination; ④ Patients with intestinal obstruction, inflammatory bowel disease, Lynch syndrome, and familial adenomatous polyposis diagnosis;
- Pregnancy; ⑥ Those who fail to meet the requirements for bowel cleansing preparation (BBPS\<6 points).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qianfoshan Hospital
Jinan, Shandong, 250014, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xinyong Jia
Qianfoshan Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- chief physician
Study Record Dates
First Submitted
September 4, 2024
First Posted
September 19, 2024
Study Start
August 1, 2021
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
September 19, 2024
Record last verified: 2024-09